Cardama Alfonso Quintas's Form 4 filing
TCR2 Therapeutics Inc. (TCRR) · filed Dec 9, 2022
- Accession no.
- 0000899243-22-038102
- Filed
- Dec 9, 2022
- Trade date
- Dec 7-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $10.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cardama Alfonso QuintasCIK 0001760104 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | Common Stock | SSaleDisposed | −3,928 | $1.28 | −$5,027.84 | 127,272 | Direct | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −4,014 | $1.26 | −$5,057.64 | 123,258 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.